CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+40.97%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$907M
AUM Growth
+$907M
Cap. Flow
+$30M
Cap. Flow %
3.31%
Top 10 Hldgs %
41.16%
Holding
94
New
10
Increased
12
Reduced
5
Closed
9

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
$23.4M
2
PTGX icon
Protagonist Therapeutics
PTGX
$16.9M
3
KA
Kineta, Inc. Common Stock
KA
$15.5M
4
MYOK
MyoKardia, Inc. Common Stock
MYOK
$13.8M
5
IVTY
Invuity, Inc
IVTY
$10.1M

Top Sells

1
TSRO
TESARO, Inc.
TSRO
$30.5M
2
NKTR icon
Nektar Therapeutics
NKTR
$28.8M
3
SAGE
Sage Therapeutics
SAGE
$22M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$18.9M
5
NVAX icon
Novavax
NVAX
$11.8M

Sector Composition

1 Healthcare 91.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALDR
1
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$55.4M 6.1% 1,689,071 – –
NVRO
2
DELISTED
NEVRO CORP.
NVRO
$51.3M 5.65% 491,044 – –
TBPH icon
3
Theravance Biopharma
TBPH
$699M
$40.5M 4.47% 1,118,372 – –
NERV icon
4
Minerva Neurosciences
NERV
$16.5M
$39.5M 4.36% 2,800,000 – –
KA
5
DELISTED
Kineta, Inc. Common Stock
KA
$36.6M 4.04% 2,350,000 +995,661 +74% +$15.5M
CLSD icon
6
Clearside Biomedical
CLSD
$28.9M
$34.5M 3.8% 1,988,208 – –
EGRX
7
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$31.9M 3.52% 455,995 -50,000 -10% -$3.5M
HRTX icon
8
Heron Therapeutics
HRTX
$207M
$30.5M 3.37% 1,771,263 – –
ARDX icon
9
Ardelyx
ARDX
$1.53B
$26.8M 2.96% 2,071,964 +572,738 +38% +$7.41M
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$26.2M 2.89% 1,605,790 +847,500 +112% +$13.8M
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
$23.4M 2.58% +650,000 New +$23.4M
ACRS icon
12
Aclaris Therapeutics
ACRS
$209M
$23.1M 2.55% 901,286 – –
QTNT
13
DELISTED
Quotient Limited Ordinary Shares
QTNT
$21.8M 2.4% 2,787,717 +1,250,000 +81% +$9.78M
GLPG icon
14
Galapagos
GLPG
$2.07B
$21.4M 2.36% 334,044 – –
MGNX icon
15
MacroGenics
MGNX
$112M
$21.2M 2.34% 707,978 – –
NBIX icon
16
Neurocrine Biosciences
NBIX
$13.8B
$20.2M 2.22% 398,301 – –
OMER icon
17
Omeros
OMER
$283M
$18.9M 2.09% 1,695,000 -15,000 -0.9% -$167K
PTGX icon
18
Protagonist Therapeutics
PTGX
$3.67B
$16.9M 1.86% +800,000 New +$16.9M
WVE icon
19
Wave Life Sciences
WVE
$1.53B
$16.5M 1.82% 507,907 +113,500 +29% +$3.69M
SRNE
20
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$16.4M 1.81% 2,121,013 – –
CHRS icon
21
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$15.4M 1.7% 576,106 – –
CBPO
22
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$14.1M 1.55% 112,867 – –
CRBP icon
23
Corbus Pharmaceuticals
CRBP
$115M
$13.6M 1.5% 2,000,000 – –
PTLA
24
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$13.5M 1.49% 596,000 +200,000 +51% +$4.54M
CLLS
25
Cellectis
CLLS
$258M
$12M 1.32% 498,117 – –
1
2 3 4